| Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth RG van der Most, AJ Currie, AL Cleaver, J Salmons, AK Nowak, ... PloS one 4 (9), e6982, 2009 | 118 | 2009 |
| A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent C Robinson, I van Bruggen, A Segal, M Dunham, A Sherwood, ... Cancer Research 66 (22), 10786-10794, 2006 | 102 | 2006 |
| Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation AJ Currie, A Prosser, A McDonnell, AL Cleaver, BWS Robinson, ... The Journal of Immunology 183 (12), 7898-7908, 2009 | 74 | 2009 |
| Transient Treg depletion enhances therapeutic anti‐cancer vaccination SA Fisher, WJ Aston, J Chee, A Khong, AL Cleaver, JN Solin, S Ma, ... Immunity, inflammation and disease 5 (1), 16-28, 2017 | 43 | 2017 |
| Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study AL Cleaver, AH Beesley, MJ Firth, NC Sturges, RA O'Leary, SP Hunger, ... Molecular Cancer 9, 105, 2010 | 43 | 2010 |
| Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation AM McDonnell, AJ Currie, M Brown, K Kania, B Wylie, A Cleaver, R Lake, ... Oncoimmunology 1 (6), 840-846, 2012 | 33 | 2012 |
| The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40 A Khong, AL Cleaver, M Fahmi Alatas, BC Wylie, T Connor, SA Fisher, ... BMC cancer 14, 1-9, 2014 | 28 | 2014 |
| Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance AL Cleaver, K Bhamidipaty, B Wylie, T Connor, C Robinson, ... Carcinogenesis 35 (2), 407-414, 2014 | 19 | 2014 |
| Neoadjuvant anti-tumor vaccination prior to surgery enhances survival SA Fisher, A Cleaver, DD Lakhiani, A Khong, T Connor, B Wylie, ... Journal of Translational Medicine 12, 1-9, 2014 | 12 | 2014 |
| A commercially available preparation of Staphylococcus aureus bio‐products potently inhibits tumour growth in a murine model of mesothelioma SM Lansley, JF Varano della Vergiliana, AL Cleaver, SH Ren, A Segal, ... Respirology 19 (7), 1025-1033, 2014 | 12 | 2014 |
| Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation AL Sherwood, SE Mutsaers, VK Peeva, C Robinson, CJ DeSilva, ... Cell Proliferation 41 (6), 894-908, 2008 | 7 | 2008 |
| S59 Chemo-immunotherapy of mesothelioma: depletion of established, suppressive CD4 T cells is critical to achieving cures in a murine model HJ Steer, A Cleaver, A Nowak, B Robinson, R Lake Thorax 66 (Suppl 4), A29-A29, 2011 | 1 | 2011 |
| Targeted depletion of regulatory T cells in solid cancers S Fisher, J Solin, W Aston, A Cleaver, WJ Lesterhuis, A Khong, ... EUROPEAN JOURNAL OF IMMUNOLOGY 46, 231-231, 2016 | | 2016 |
| Combining Prime-Boost Anti-tumour Vaccination with Debulking Surgery for the Treatment of Solid Tumours. SA Fisher, AL Cleaver, A Khong, T Connor, B Wylie, D Lakhiani, C Boylen, ... Front. Immunol. Conference Abstract: 15th International Congress of …, 2013 | | 2013 |
| THE EFFECTS OF PARTIAL DEBULKING SURGERY ON TUMOR GROWTH, SURVIVAL AND TUMOR SPECIFIC IMMUNE RESPONSES FA Mohamad, A Cleaver, B Robinson RESPIROLOGY 16, 172-172, 2011 | | 2011 |
| Research Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study AL Cleaver, AH Beesley, MJ Firth, NC Sturges, RA O'Leary, SP Hunger, ... methods 2, 4, 2010 | | 2010 |
| Characterisation of a Mouse Model of Mesothelial Cell Transformation AL Sherwood University of Western Australia, 2006 | | 2006 |
| WS/PP-093a-006 Tumor specific CD4 cells change the phenotype of Tumor Associated Macrophages from tumor “nurturing” to anti-angiogenic A. Perez-Diez, P. Matzinger. NIAID … A Cleaver, R Weller, K Kania, S Broomfield, R Lake, A Currie | | |
| Using our established mouse model of mesothelioma, AB1-HA tumour bearing mice received influenza A PR8 (prime) and rMVA-HA (boost) anti-tumour vaccinations, either before … SA Fisher, AL Cleaver, A Khong, T Connor, B Wylie, D Lakhiani, ... | | |
